Skip to main navigation Skip to search Skip to main content

Adoptive T-cell therapy against cancer using tumor-infiltrating lymphocytes (TIL) and gene engineered T cells

Research output: Other contribution

Original languageUndefined/Unknown
StatePublished - Feb 20 2025

Publication series

NameArticles, Abstracts, and Reports

Cite this